Publication | Closed Access

Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality

Circulatory-renal LimitationsHypertensionHeart FailureSevere Heart FailureCardiorenal SyndromesCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular PharmacologyVascular BiologyChronic Kidney DiseaseNephrologyDiastolic FunctionEarly MortalityAnesthesiology